Dabrafenib and trametinib therapy in an elderly patient with non‐small cell lung cancer harboring the BRAF V600E mutation

Dabrafenib and trametinib therapy for BRAF V600E‐mutant non‐small cell lung cancer (NSCLC) has demonstrated strong antitumor effects in clinical trials and has been approved for use in clinical practice. However, the efficacy and safety of this combination therapy in elderly patients remain unclear....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorac Cancer
Main Authors: Dotsu, Yosuke, Fukuda, Minoru, Honda, Noritaka, Gyotoku, Hiroshi, Kohno, Yoshihisa, Suyama, Takayuki, Umeyama, Yasuhiro, Taniguchi, Hirokazu, Takemoto, Shinnosuke, Yamaguchi, Hiroyuki, Miyazaki, Taiga, Sakamoto, Noriho, Obase, Yasushi, Ikeda, Hiroaki, Ashizawa, Kazuto, Mukae, Hiroshi
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons Australia, Ltd 2020
Assuntos:
Case Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7812073/
https://ncbi.nlm.nih.gov/pubmed/33215864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13756
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados